Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tianyin Pharmaceutical Co (TPI)

Tianyin Pharmaceutical Co (TPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tianyin Pharmaceutical Co 23RD FLOOR UNIONSUN YANGKUO PLAZA NO.2 BLOCK 3 RENMIN ROAD SOUTH CHENGDU P.R. F4 610041

www.tianyinpharma.com P: 00-86-028-8551-6696

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

TIANYIN is a manufacturer and supplier of modernized Traditional Chinese Medicine in China. It has a comprehensive product portfolio of 33 modernized TCMs and 4 generic western medicines in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 48 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople.

Key Statistics

Overview:

Market Capitalization, $K 4,150
Shares Outstanding, K 29,430
% of Insider Shareholders 29.04%
% of Institutional Shareholders 6.92%

Financials:

Annual Sales, $ 46,560 K
Annual Net Income, $ -640 K
Last Quarter Sales, $ 644 K
Last Quarter Net Income, $ -447 K

Growth:

1-Year Return -69.39%
3-Year Return -75.41%
5-Year Return -93.15%
5-Year Revenue Growth 8.56%
5-Year Earnings Growth -108.82%
5-Year Dividend Growth -100.00%

Per-Share Information:

Next Earnings Date 08/09/16
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.025 on 01/27/10
Dividend Payable Date 03/10/10
Dividend Payout Ratio 0.00%

TPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -1.37%
Debt/Equity 0.00
Price/Sales 0.26
Price/Cash Flow 2.36
Price/Book 0.05
Book Value/Share 0.00
Interest Coverage 0.00
60-Month Beta 2.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar